Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
7.20
-0.20 (-2.70%)
Aug 14, 2025, 1:33 PM - Market open
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $4.04 million as of August 14, 2025. Its market cap has decreased by -91.16% in one year.
Market Cap
4.04M
Enterprise Value
7.46M
1-Year Change
-91.16%
Ranking
Category
Stock Price
7.20
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $4.04M, a decrease of -97.28%. That is a compound annual growth rate of -56.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 4.15M | 28.83% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
| Apr 7, 2021 | 148.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |